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ABSTRACT 
The  significance  of  a  subcentimetre 
18F-FDG  PET/CT  pulmonary  abnormality  in  a  patient  with  known 
extrapulmonary primary malignancy can have a major impact on the clinical management of the patient. The clinician’s 
reliance on the semi-quantitative and qualitative PET/CT analysis of the abnormality has, at times, led to untoward 
diagnostic problems, given the limited spatial resolution of PET for a small volume lesion performed as part of the 
standard PET/CT study. This paper highlights a case each of an FDG-positive and an FDG-negative focal pulmonary 
abnormality in a combined PET/CT study of patients with known extrapulmonary malignancy. © 2010 Biomedical 
Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Subcentimetre  pulmonary  abnormality  is  not  an 
uncommon  incidental  finding  on  Positron  Emission 
Tomography/Computed  Tomography  (PET/CT)  studies 
performed  in  patients  with  known  extrapulmonary 
malignancy  [1].  It  may  be  difficult  to  ascertain  the 
aetiology  of  such  abnormalities  on  the  PET/CT 
assessment and this may pose a diagnostic challenge to 
the physician when attempting to adopt an appropriate 
management  plan.  A  subcentimetre  pulmonary 
abnormality  can  have  many  aetiologies,  ranging  from 
benign  lesions,  such  as  granuloma  or  inflammatory 
lesions, to a malignant pathology, such as metastasis or 
primary  lung  malignancy  [1]. 
18F-Fluorodeoxyglucose 
(
18F-FDG)  PET  has  been  used  to  triage  the  clinical 
significance  of  small  pulmonary  lesions,  and  helps  to 
devise  appropriate  management  strategies.  However, 
some  tumours  with  high  malignant  potential  can  have 
relatively low FDG-uptake [2]. Prediction of malignancy 
for small PET-negative nodule may be low and Joo et al. 
has  reported  that  there  is  more  than  19%  risk  of 
malignancy in subcentimetre FDG-negative nodules [1]. 
This is further substantiated by most reports, which have 
suggested that the reliability of minimal SUV value of a 
subcentimetre pulmonary abnormality is not compelling 
[3].  On  the  other  hand,  an  FDG-positive  pulmonary 
abnormality  has  a  higher  chance  of  being  malignant. 
Using a semi-quantitative test in PET, the accuracy of 
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Figure 1 Correlative images of PET/CT (taken February 2007); The right PET image displayed an 
avid FDG (SUV max of 17.9) focus in the apical segment of the left lower lobe without 
any apparent nodules on the corresponding CT image on the left. 
 
Figure 2 Correlative images of PET/CT (taken September 2007); The previously documented focal 
FDG uptake in the left lung has resolved, consistent with an FDG microembolus rather 
than metastatic disease. 
standardised  uptake  value  (SUV  max),  which  has  a 
cutoff of 2.5 to indicate a malignancy, improved with an 
increase  in  the  diameter  of  the  pulmonary  nodule  in 
question [2].  
This paper presents one case each of a PET-positive 
and  a  PET-negative  of  a  subcentimetre  pulmonary 
abnormality in a combined PET/CT study and highlights 
the  significance  of  their  existence  in  patients  with 
extrapulmonary malignancy. 
CASE REPORT 1 
A 61-year-old lady with a history of nodal positive 
right  breast  cancer  was  treated  by  surgery  and 
chemotherapy in 1996. She was referred for a PET/CT in 
February 2007 with the query of locoregional recurrence 
because of recurrent chest wall pain. A PET/CT study 
revealed a highly intense focus in the apical segment of 
the left lower lobe on the PET images but there was no 
perceptible  nodule  on  the  corresponding  CT  images 
(Figure 1).  Given  the  superior  sensitivity  of  the  co-
registered  CT  images  in  the  detection  of  pulmonary 
nodules,  the  PET  abnormality  was  not  considered  to 
represent  pulmonary  metastasis  and  a  provisional 
diagnosis  of  an  FDG  microembolus  was  made.  The 
patient was managed conservatively. Follow-up PET/CT 
performed  seven  months  later  demonstrated  complete 
resolution  of  the  PET  abnormality  and  reaffirmed  the 
original diagnosis (Figure 2). 
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Figure 3 Correlative images of PET/CT revealed a 5 × 9 mm nodule in the anterior segment of the 
right upper lobe with minimal FDG avidity. 
 
Figure 4 Correlative PET/CT images displayed that the SUV max of the right upper lobe nodule (0.9) 
is less than that of the mediastinal blood pool (2.1). 
CASE REPORT 2 
A  69-year-old  male,  with  a  history  of  Stage  II 
colonic cancer resected two years prior, presented for a 
PET scan to assess a progressive right upper lobe (RUL) 
nodule on serial CTs. On PET, there was a 5 × 9 mm 
nodule with minimal FDG avidity (SUV max: 0.87), of 
which visual intensity is less than that of the mediastinal 
blood  pool  (Figures 3  and  4).  The  nodule  was  still 
considered  to  have  a  significant  malignant  potential 
given its small size and progressive nature on serial CTs 
despite its low FDG intrinsic nature. Biopsy of the lesion 
revealed a low grade adenocarcinoma, consistent with a 
primary lung cancer. 
DISCUSSION 
The  PET-positive  SPN  in  Case  Report  1  was 
considered to be a benign FDG microembolus given the 
absence of a nodule on the co-registered CT images, and 
this was confirmed by its spontaneous resolution on the 
follow  up  PET/CT  study.  An  FDG-microembolus 
resulting from FDG-tracer contamination at the injection 
site  is  an  uncommon  phenomenon,  which  may  be 
incidentally encountered during a routine PET/CT study 
[4].  This  may  be  suspected  when  there  are  no 
corresponding nodules on the CT to account for a highly 
avid  FDG  focus,  with  the  understanding  that  the  co-
registered CT images are invariably more sensitive than 
PET due to its superior contrast and spatial resolution in 
the  lungs  [2].  In  general,  a  genuine  FDG  avid  lung Fathinul Fikri and Lau Biomed Imaging Interv J 2010; 6(4):e3    4 
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tumour  must  be  seen  on  CT  to  be  confirmed. 
Nonetheless,  the  presence  of  high  FDG  avidity  in  a 
pulmonary  nodule  seen  on  CT  is  highly  predictive  of 
malignancy;  and  a  malignant  final  diagnosis  is 
approximately  10  times  more  likely  than  a  benign 
aetiology  when  PET  results  are  rated  ‘definitely 
malignant’ [5].  
In  the  second  case  report,  the  subcentimetre 
pulmonary abnormality was considered a PET-negative 
lesion  based  on  both  semi-quantitative  and  qualitative 
criteria of its low FDG avidity when compared to the 
mediastinal  blood  pool  [1,  5].  Its  low  intrinsic  FDG 
avidity  was,  however,  interpreted  in  the  setting  of  a 
corresponding  small  progressive  nodule  on  CT, 
suggesting a strong suspicion of a small volume or low 
grade  malignancy  [1,  5].  This  is  explained  by  the 
presence of relatively low metabolic activity in certain 
malignant  nodules,  as  well  as  the  effect  of  respiratory 
blurring  and  partial  voluming  in  small  nodules.  These 
factors  limit  the  ability  of  the  co-registered  PET/CT 
images  to  differentiate  benign  from  malignant  nodules 
[2]. The histological diagnosis of the nodule in question 
was  a  low  grade  adenocarcinoma  which  is  known  to 
exhibit low FDG uptake.  
These  two  case  reports  illustrate  how  a  reliable 
differentiation  between  malignant  and  benign  nodules 
based  on  the  co-registered  PET/CT  information  is,  at 
times,  equivocal,  and  therefore  serves  as  diagnostic 
challenges  to  the  interpreter.  Despite  the  high  contrast 
resolution  of  the  co-registered 
18F-FDG  PET  in  the 
detection of lung disease, its finite spatial resolution and 
the  potential  respiratory  blurring  limit  a  combined 
PET/CT ability to assess a subcentimetre nodule. In this 
context,  the  standard  care  of  the  combined  PET 
interpretation  with  corresponding  CT  in  evaluating  a 
subcentimetre  pulmonary  nodule  requires  a  meticulous 
correlation  with  the  clinical  course  of  the  disease,  the 
substantiation  of  the  PET  technology  through  the 
respiratory gating technique, and the use of alternative 
PET radiotracers, such as 
18F-fluoro-thymidine (FLT) . 
CONCLUSION 
The significance of PET-positive and PET-negative 
subcentimetre  pulmonary  abnormality  in  a  combined 
PET/CT  study,  at  times,  cause  diagnostic  uncertainty, 
which poses a problem in the disease management plan. 
These case reports document the difficulties of using the 
standard combined PET/CT to determine the malignancy 
potential  of a  subcentimetre  pulmonary abnormality in 
patients with extrapulmonary malignancy. 
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